Overview

CP-690-550 Ointment For Chronic Plaque Psoriasis

Status:
Completed

Trial end date:
2011-11-29

Target enrollment:

Participant gender:

Summary

The study is being conducted to see whether CP-690,550 ointment has potential as a safe and effective treatment for adult patients with mild to moderate chronic plaque psoriasis.

Phase:

Phase 2

Details

Lead Sponsor:

Pfizer

Treatments:

Tofacitinib